ACU
Acme UnitedANYSE American / Health Care Equipment & Services
Last Price
At close
2026-07-22
Current thesis
ACU delivered 14% Q1 sales growth, added MyMedic, and is pursuing distribution expansion, cost synergies, facility consolidation, and automation. If tariff-related cost pressure fades and seasonal MyMedic earnings materialize, profitability could improve in the second half of 2026.
Posture
Constructive
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-07-23 · BMO.
What can break
MyMedic is seasonal and may require continued advertising and integration spending before contributing meaningfully to profit.
Momentum
79
Value
63
Sentiment
60
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $52.00 · Bull $58.00 · Bear $39.00
Earnings
2026-07-23 · BMO
Data freshness
Prices
As of 2026-07-22
Fundamentals
As of 2026-07-22 • Vendor: Data Vendor v1
Scores
As of 2026-07-22 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-22
Investment thesis
As of 2026-07-22
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $52.00
Why
Momentum79 · Δ7d -
Value63 · Δ7d +0.2
Sentiment60 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
79
26% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
63
39% active weight
Current posture
7d trendFlat
Δ7d
+0.2
Δ21d
+1.0
Sentiment
60
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade A. Momentum 79.1 / Value 62.5 / Sentiment 59.6
Fundamentals (TTM)As of 2026-07-22
Fundamentals (TTM)
As of 2026-07-22
Market Cap
$174.9M
Beta
0.75
Shares Out
3.81M
P/E (TTM)
16.5
P/S (TTM)
0.79
P/FCF (TTM)
34.25
Rev YoY
+13.8%
EPS YoY
-41.7%
Gross Margin
+39.6%
Op Margin
+7.2%
Net Debt
$25.12M
Current Ratio
4.57
As of 2026-07-22 • Updated nightlySource: Internal modelMethodology